Eurofins · 13 hours ago
Cell Core Analyst
Eurofins is an international life sciences company providing analytical testing services across multiple industries. The Cell Core Analyst will maintain multiple cell lines for clinical bioassay testing and ensure compliance with standard operating procedures while supporting laboratory operations.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Maintain both suspension and adherent mammalian cell lines
Support any thawing or banking activities for clinical cell lines
Prepare required media for cell lines
Follow and comply with all governing standard operating procedures
Complete laboratory documentation and review logbook data
Calibrate or verify calibration of instruments/devices prior to use
Participate in required training activities
Maintain laboratory supplies
Interact with outside customers or functional peer groups
Qualification
Required
Bachelor's degree in biochemistry or other science related degree concentration
Experience with handling of mammalian cell lines
Experience operating within a GMP environment
Expert in pipetting and pipetting technique
Authorization to work in the United States indefinitely without restriction or sponsorship
Preferred
Is self-motivated, adaptable, team-oriented, and has a positive attitude
Ability to learn new techniques, perform multiple tasks simultaneously, keep accurate records, follow instructions, and comply with company policies
Excellent communication (oral and written) and attention to detail
Desire to work in a moderately physical role that requires standing much of the time
Strong computer and organizational skills
Fosters a healthy, trusting environment and champions transparency and communication
GMP, biopharmaceutical, or other related industry experience
Familiarity with LIMS
Benefits
Comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase